|
1
|
Roughley PJ: Articular cartilage and
changes in arthritis: noncollagenous proteins and proteoglycans in
the extracellular matrix of cartilage. Arthritis Res. 3:342–347.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eyre D: Collagen of articular cartilage.
Arthritis Res. 4:30–35. 2002. View
Article : Google Scholar
|
|
3
|
Davidson RK, Waters JG, Kevorkian L,
Darrah C, Cooper A, Donell ST and Clark IM: Expression profiling of
metalloproteinases and their inhibitors in synovium and cartilage.
Arthritis Res Ther. 8:R1242006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dean DD, Martel-Pelletier J, Pelletier JP,
Howell DS and Woessner JF Jr: Evidence for metalloproteinase and
metalloproteinase inhibitor imbalance in human osteoarthritic
cartilage. J Clin Invest. 84:678–685. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hughes CE, Little CB, Büttner FH, Bartnik
E and Caterson B: Differential expression of aggrecanase and matrix
metalloproteinase activity in chondrocytes isolated from bovine and
porcine articular cartilage. J Biol Chem. 273:30576–30582. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pullig O, Weseloh G, Gauer S and Swoboda
B: Osteopontin is expressed by adult human osteoarthritic
chondrocytes: protein and mRNA analysis of normal and
osteoarthritic cartilage. Matrix Biol. 19:245–255. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McKee MD, Glimcher MJ and Nanci A:
High-resolution immunolocalization of osteopontin and osteocalcin
in bone and cartilage during endochondral ossification in the
chicken tibia. Anat Rec. 234:479–492. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Honsawek S, Tanavalee A, Sakdinakiattikoon
M, Chayanupatkul M and Yuktanandana P: Correlation of plasma and
synovial fluid osteopontin with disease severity in knee
osteoarthritis. Clin Biochem. 42:808–812. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao SG, Li KH, Zeng KB, Tu M, Xu M and Lei
GH: Elevated osteopontin level of synovial fluid and articular
cartilage is associated with disease severity in knee
osteoarthritis patients. Osteoarthritis Cartilage. 18:82–87. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Attur MG, Dave MN, Stuchin S, Kowalski AJ,
Steiner G, Abramson SB, Denhardt DT and Amin AR: Osteopontin: an
intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum.
44:578–584. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsui Y, Iwasaki N, Kon S, Takahashi D,
Morimoto J, Matsui Y, Denhardt DT, Rittling S, Minami A and Uede T:
Accelerated development of aging-associated and instability-induced
osteoarthritis in osteopontin-deficient mice. Arthritis Rheum.
60:2362–2371. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pelletier JP, Mineau F, Faure MP and
Martel-Pelletier J: Imbalance between the mechanisms of activation
and inhibition of metalloproteases in early lesions of experimental
osteoarthritis. Arthritis Rheum. 33:1466–1476. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Knäuper V, López-Otin C, Smith B, Knight G
and Murphy G: Biochemical characterization of human collagenase-3.
J Biol Chem. 271:1544–1550. 1996.
|
|
14
|
Tetlow LC, Adlam DJ and Woolley DE: Matrix
metalloproteinase and proinflammatory cytokine production by
chondrocytes of human osteoarthritic cartilage: associations with
degenerative changes. Arthritis Rheum. 44:585–594. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dean DD and Woessner JF Jr: Extracts of
human articular cartilage contain an inhibitor of tissue
metalloproteinases. Biochem J. 218:277–280. 1984.PubMed/NCBI
|
|
16
|
Goldberg GI, Marmer BL, Grant GA, Eisen
AZ, Wilhelm S and He CS: Human 72-kilodalton type IV collagenase
forms a complex with a tissue inhibitor of metalloproteases
designated TIMP-2. Proc Natl Acad Sci USA. 86:8207–8211. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chevalier X, Conrozier T, Gehrmann M,
Claudepierre P, Mathieu P, Unger S and Vignon E: Tissue inhibitor
of metalloprotease-1 (TIMP-1) serum level may predict progression
of hip osteoarthritis. Osteoarthritis Cartilage. 9:300–307. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Petrow PK, Hummel KM, Schedel J, Franz JK,
Klein CL, Müller-Ladner U, Kriegsmann J, Chang PL, Prince CW, Gay
RE and Gay S: Expression of osteopontin messenger RNA and protein
in rheumatoid arthritis: effects of osteopontin on the release of
collagenase 1 from articular chondrocytes and synovial fibroblasts.
Arthritis Rheum. 43:1597–1605. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ohshima S, Kobayashi H, Yamaguchi N,
Nishioka K, Umeshita-Sasai M, Mima T, Nomura S, Kon S, Inobe M,
Uede T and Saeki Y: Expression of osteopontin at sites of bone
erosion in a murine experimental arthritis model of
collagen-induced arthritis: possible involvement of osteopontin in
bone destruction in arthritis. Arthritis Rheum. 46:1094–1101. 2002.
View Article : Google Scholar : PubMed/NCBI
|
